Clinical Trials Logo
  1. Home
  2. T1DM
  3. NCT03697369

Glycemic Control and Treatment Satisfaction in Children With Type 1 Diabetes Using Insulin Pumps

T1DM Clinical Trial

Official title:
Glycemic Control and Treatment Satisfaction in Children With Type 1 Diabetes Using Insulin Pumps

Clinical Trial Summary

Background: The use of insulin pumps in pediatric patients with type 1 diabetes(T1D) has expanded, with lack of data comparing between the different devices.

Objective: to compare prospectively glycemic control, technical difficulties and quality of life (QOL) between 3 pump devices during the first year of use .

Methods: a prospective observational trial, based on clinical data retrieved during 12 months of follow- up. Inclusion criteria included T1D patients, ages 1-18 years, who started pump therapy as part of their clinical care in 4 university affiliated medical centers. The devices fully reimbursed by national health insurance are: MiniMed™ 640G , MiniMed® Veo™, Animas® Vibe®, and Abbott Omnipod®. Comparison parameters included quality of life (QOL), frequency of technical difficulties, skin reactions, discontinuation rate, glycated hemoglobin (HBA1C), mean glucose, total daily insulin dose (TDD) , pump setting parameters and BMI.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03697369
Study type Observational
Source Assaf-Harofeh Medical Center
Contact
Status Completed
Phase
Start date May 31, 2015
Completion date August 31, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03335878 - Brain Health and Development With T1DM
Not yet recruiting NCT04421001 - RCT for Evaluation of Insulin Administration,While Using the iPORT System N/A
Withdrawn NCT04428762 - Glycemic Control and Quality of Life With i- Port Advance in Pediatric T1DM N/A
Completed NCT03594565 - The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series Early Phase 1
Completed NCT04756011 - Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)
Completed NCT02293837 - Tocilizumab (TCZ) in New-onset Type 1 Diabetes Phase 2
Recruiting NCT04412200 - Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus N/A
Not yet recruiting NCT04054934 - Influence of Circadian Clock on Hormonal, Metabolic, Neurocognitive Markers in Adolescents With and Without Diabetes
Recruiting NCT02734277 - Type 1 Diabetes Extension Study